Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    44 - I support a number of small products which are supported by one sales force. In order to simplify detailing efforts, I would like to produce one detail aid for all the products, with a few pages dedicated to each one. When it comes to the prescribing summaries, should these be placed together at the end of the detail aid, or with the pages related to that product?

    Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists
    1
    1
    30
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Either option is fine. Another option would be to have loose-leaf prescribing information (PI) for each product that the representatives could distribute on request. The reps could offer the PI at the time of promotion of the detail aid. Code s7.3 says the PI "should form an integral part of the presentation or be attached to it". So it can be loose and accompany the piece. The doctor may choose only those PIs that he or she may want. We can save some trees.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post